|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sveen A, Kopetz S and Lothe RA:
Biomarker-guided therapy for colorectal cancer: Strength in
complexity. Nat Rev Clin Oncol. 17:11–32. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martins BA, de Bulhoes GF, Cavalcanti IN,
Martins MM, de Oliveira PG and Martins AMA: Biomarkers in
colorectal cancer: The role of translational proteomics research.
Front Oncol. 9:12842019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(review). Mol Med Rep. 11:1566–1572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun X and Kaufman PD: Ki-67: More than a
proliferation marker. Chromosoma. 127:175–186. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang C, Zhang J, Ding M, Xu K, Li L, Mao L
and Zheng J: Ki67 targeted strategies for cancer therapy. Clin
Transl Oncol. 20:570–575. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petrowsky H, Sturm I, Graubitz O, Kooby
DA, Staib-Sebler E, Gog C, Köhne CH, Hillebrand T, Daniel PT, Fong
Y and Lorenz M: Relevance of Ki-67 antigen expression and K-ras
mutation in colorectal liver metastases. Eur J Surg Oncol.
27:80–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weber JC, Nakano H, Bachellier P,
Oussoultzoglou E, Inoue K, Shimura H, Wolf P, Chenard-Neu MP and
Jaeck D: Is a proliferation index of cancer cells a reliable
prognostic factor after hepatectomy in patients with colorectal
liver metastases? Am J Surg. 182:81–88. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roxburgh CS, Richards CH, Macdonald AI,
Powell AG, McGlynn LM, McMillan DC, Horgan PG, Edwards J and Shiels
PG: The in situ local immune response, tumour senescence and
proliferation in colorectal cancer. Br J Cancer. 109:2207–2216.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Melling N, Kowitz CM, Simon R, Bokemeyer
C, Terracciano L, Sauter G, Izbicki JR and Marx AH: High Ki67
expression is an independent good prognostic marker in colorectal
cancer. J Clin Pathol. 69:209–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo ZW, Zhu MG, Zhang ZQ, Ye FJ, Huang WH
and Luo XZ: Increased expression of Ki-67 is a poor prognostic
marker for colorectal cancer patients: A meta analysis. BMC Cancer.
19:1232019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong DD, Lin XG, He RQ, Pan DH and Gan
TQ: Ki67/MIB-1 predicts better prognoses in colorectal cancer
patients received both surgery and adjuvant radio-chemotherapy: A
meta-analysis of 30 studies. Int J Clin Exp Med. 10:1788–1804.
2017.
|
|
13
|
Chan GHJ and Chee CE: Making sense of
adjuvant chemotherapy in colorectal cancer. J Gastrointest Oncol.
10:1183–1192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sabattini E, Bisgaard K, Ascani S, Poggi
S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G and
Pileri SA: The EnVision++ system: A new immunohistochemical method
for diagnostics and research. Critical comparison with the APAAP,
ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol.
51:506–511. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tong G, Zhang G, Liu J, Zheng Z, Chen Y,
Niu P and Xu X: Cutoff of 25% for Ki67 expression is a good
classification tool for prognosis in colorectal cancer in the AJCC8
stratification. Oncol Rep. 43:1187–1198. 2020.PubMed/NCBI
|
|
16
|
Gerdes J, Schwab U, Lemke H and Stein H:
Production of a mouse monoclonal antibody reactive with a human
nuclear antigen associated with cell proliferation. Int J Cancer.
31:13–20. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobecki M, Mrouj K, Camasses A, Parisis N,
Nicolas E, Llères D, Gerbe F, Prieto S, Krasinska L, David A, et
al: The cell proliferation antigen Ki-67 organises heterochromatin.
Elife. 5:e137222016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mrouj K, Andres-Sanchez N, Dubra G, Singh
P, Sobecki M, Chahar D, Ghoul EA, Aznar AB, Prieto S, Pirot N, et
al: Ki-67 regulates global gene expression and promotes sequential
stages of carcinogenesis. Proc Natil Acad Sci USA.
118:e20265071182021. View Article : Google Scholar
|
|
19
|
Soliman NA and Yussif SM: Ki-67 as a
prognostic marker according to breast cancer molecular subtype.
Cancer Biol Med. 13:496–504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin B, Paesmans M, Mascaux C, Berghmans
T, Lothaire P, Meert AP, Lafitte JJ and Sculier JP: Ki-67
expression and patients survival in lung cancer: Systematic review
of the literature with meta-analysis. Br J Cancer. 91:2018–2025.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fluge O, Gravdal K, Carlsen E, Vonen B,
Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM,
et al: Expression of EZH2 and Ki-67 in colorectal cancer and
associations with treatment response and prognosis. Br J Cancer.
101:1282–1289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kikuchi M, Mikami T, Sato T, Tokuyama W,
Araki K, Watanabe M, Saigenji K and Okayasu I: High Ki67, Bax, and
thymidylate synthase expression well correlates with response to
chemoradiation therapy in locally advanced rectal cancers: Proposal
of a logistic model for prediction. Br J Cancer. 101:116–123. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allegra CJ, Paik S, Colangelo LH, Parr AL,
Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N and Wieand HS:
Prognostic value of thymidylate synthase, Ki-67, and p53 in
patients with Dukes' B and C colon cancer: A national cancer
institute-national surgical adjuvant breast and bowel project
collaborative study. J Clin Oncol. 21:241–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swiderska-Chadaj Z, Markiewicz T, Grala B
and Lorent M: Content-based analysis of Ki-67 stainedmeningioma
specimens for automatic hot-spot selection. Diagn Pathol.
11:932016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leung SCY, Nielsen TO, Zabaglo L, Arun I,
Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A,
et al: Analytical validation of a standardized scoring protocol for
Ki67: Phase 3 of an international multicenter collaboration. NPJ
Breast Cancer. 2:160142016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shin IY, Sung NY, Lee YS, Kwon TS, Si Y,
Lee YS, Oh ST and Lee IK: The expression of multiple proteins as
prognostic factors in colorectal cancer: Cathepsin D, p53, COX-2,
epidermal growth factor receptor, C-erbB-2, and Ki-67. Gut Liver.
8:13–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu XS, Xi HQ and Chen L: Lgr5 is a
potential marker of colorectal carcinoma stem cells that correlates
with patient survival. World J Surg Oncol. 10:2442012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alba E, Lluch A, Ribelles N, Anton-Torres
A, Sanchez-Rovira P, Albanell J, Calvo L, García-Asenjo JAL,
Palacios J, Chacon JI, et al: High proliferation predicts
pathological complete response to neoadjuvant chemotherapy in early
breast cancer. Oncologist. 21:150–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
